Combined ANCA-associated Vasculitis and Lupus Syndrome Following Prolonged Use of Hydralazine: a Timely Reminder of an Old Foe

Overview

Journal Int Urol Nephrol

Publisher Springer

Specialty Nephrology

Date 2009 Aug 18

PMID 19685279

Citations 3

Authors

N Sangala

R W Lee

C Horsfield

D J A Goldsmith

Affiliations

Soon will be listed here.

Citing Articles

Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis.

Jarrot P, Chiche L, Hervier B, Daniel L, Vuiblet V, Bardin N Medicine (Baltimore). 2016; 95(22):e3748.

PMID: 27258503 PMC: 4900711. DOI: 10.1097/MD.0000000000003748.

Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects.

Grau R Curr Rheumatol Rep. 2015; 17(12):71.

PMID: 26503355 DOI: 10.1007/s11926-015-0545-9.

Antineutrophil cytoplasmic antibodies, autoimmune neutropenia, and vasculitis.

Grayson P, Sloan J, Niles J, Monach P, Merkel P Semin Arthritis Rheum. 2011; 41(3):424-33.

PMID: 21507463 PMC: 3163109. DOI: 10.1016/j.semarthrit.2011.02.003.

References

Liapis H, Tsokos G . Pathology and immunology of lupus glomerulonephritis: can we bridge the two?. Int Urol Nephrol. 2007; 39(1):223-31. DOI: 10.1007/s11255-006-9170-x. View

Taylor A, Ziesche S, Yancy C, Carson P, DAgostino Jr R, Ferdinand K . Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004; 351(20):2049-57. DOI: 10.1056/NEJMoa042934. View

Bosch X, Guilabert A, Espinosa G, Mirapeix E . Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA. 2007; 298(6):655-69. DOI: 10.1001/jama.298.6.655. View

Nassberger L, Sjoholm A, Jonsson H, Sturfelt G, Akesson A . Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol. 1990; 81(3):380-3. PMC: 1534988. DOI: 10.1111/j.1365-2249.1990.tb05342.x. View

Cameron H, Ramsay L . The lupus syndrome induced by hydralazine: a common complication with low dose treatment. Br Med J (Clin Res Ed). 1984; 289(6442):410-2. PMC: 1442447. DOI: 10.1136/bmj.289.6442.410. View

Morrow J, Schroeder H, PERRY Jr H . Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects. Circulation. 1953; 8(6):829-39. DOI: 10.1161/01.cir.8.6.829. View

Harland S, Ryan P, Bernstein R, Dollery C, Hughes G, Bulpitt C . Hydralazine, antinuclear antibodies, and the lupus syndrome. Br Med J (Clin Res Ed). 1982; 284(6320):936-9. PMC: 1496454. DOI: 10.1136/bmj.284.6320.936. View

Shapiro K, Pinn V, Harrington J, Levey A . Immune complex glomerulonephritis in hydralazine-induced SLE. Am J Kidney Dis. 1984; 3(4):270-4. DOI: 10.1016/s0272-6386(84)80044-x. View

Spronk P, Bootsma H, Horst G, Huitema M, Limburg P, Tervaert J . Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol. 1996; 35(7):625-31. DOI: 10.1093/rheumatology/35.7.625. View

10.

Bonaci-Nikolic B, Nikolic M, Andrejevic S, Zoric S, Bukilica M . Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther. 2005; 7(5):R1072-81. PMC: 1257438. DOI: 10.1186/ar1789. View

11.

Martinez-Vea A, Ferrer I, Carcia C, Mayayo E, Oliver J, Richart C . Systemic vasculitis resembling periarteritis nodosa in the lupus-like syndrome induced by hydralazine. Am J Nephrol. 1987; 7(1):71-3. DOI: 10.1159/000167435. View

12.

Birnbaum B, Sidhu G, Smith R, Pillinger M, Tagoe C . Fulminating hydralazine-induced lupus pneumonitis. Arthritis Rheum. 2006; 55(3):501-6. DOI: 10.1002/art.21987. View

13.

Short A, Lockwood C . Antigen specificity in hydralazine associated ANCA positive systemic vasculitis. QJM. 1995; 88(11):775-83. View